ON THIS PAGE: You will find information about the number of people who are diagnosed with kidney cancer each year. You will also read general information on surviving the disease. Remember, survival rates depend on several factors. Use the menu to see other pages.
This year, an estimated 79,000 adults (50,290 men and 28,710 women) in the United States will be diagnosed with kidney cancer. Worldwide, an estimated 431,288 people were diagnosed with kidney cancer in 2020.
In the United States, kidney cancer is the sixth most common cancer for men. It is the ninth most common cancer for women. The average age at diagnosis for people with kidney cancer is 64, and most people are diagnosed between the ages of 65 and 74. Kidney cancer is not common in people younger than age 45. It is more common in Black people and American Indian people.
The number of new kidney cancers in the United States has been increasing for several decades, although that increase has slowed in recent years. Between 2009 and 2018, rates rose by around 1% each year. Some of the increase has been due to an increase in the overall use of imaging tests. Imaging tests can find small kidney tumors unexpectedly when the tests are done for another reason unrelated to the cancer.
It is estimated that 13,920 deaths (8,960 men and 4,960 women) from this disease will occur in the United States this year. Between 2015 and 2019, deaths from kidney cancer decreased by 2.5% per year. In 2020, an estimated 179,368 people worldwide died from kidney cancer.
The 5-year survival rate tells you what percent of people live at least 5 years after the cancer is found. Percent means how many out of 100. The 5-year survival rate for people with kidney cancer in the United States is 76%. However, survival rates depend on several factors, including the type, cell type, and stage of the cancer when it is first diagnosed.
About two-thirds of people are diagnosed when the cancer is located only in the kidney. For this group, the 5-year survival rate is 93%. If kidney cancer has spread to surrounding tissues or organs and/or the regional lymph nodes, the 5-year survival rate is 71%. If the cancer has spread to a distant part of the body, the 5-year survival rate is 14%.
Researchers continue to study how certain factors affect survival rates, including tumor size, whether the cancer involves the lymph nodes, and how far the cancer has spread. Many of these studies calculate survival rates after surgery is done. These studies suggest that kidney cancer that spreads to the lymph nodes or distant areas of the body will have lower survival rates. However, recent advances in treatment, especially with immunotherapy (see Types of Treatment), are allowing some people with metastatic kidney cancer to live much longer than before.
It is important to remember that statistics on survival rates for people with kidney cancer are an estimate. The estimate comes from annual data based on the number of people with this cancer in the United States. Also, experts measure the survival statistics every 5 years. This means the estimate may not reflect the results of advancements in how kidney cancer is diagnosed or treated from the last 5 years. Talk with your doctor if you have any questions about this information. Learn more about understanding statistics.
Statistics adapted from the American Cancer Society's (ACS) publication, Cancer Facts & Figures 2022, the ACS website, and the International Agency for Research on Cancer website. (All sources accessed January 2022.)
The next section in this guide is Medical Illustrations. It offers drawings of body parts often affected by kidney cancer. Use the menu to choose a different section to read in this guide.